PROTEOfectene® AB complexates antibodies noncovalently by means of electrostatic and hydrophobic interactions, forming a proteoplex which is taken up by cells through endocytosis and finally releases the antibodies in the cell cytosol while retaining full functionality and maintaining epitopic binding affinity. PROTEOfectene® AB can be used to introduce mono- and polyclonal antibodies of all isotypes.
E020-0.25
METAFECTENE® FluoR is designed for transient transfection of mammalian cell lines and primary cells with DNA (plasmids, bacmids). By the fluorescent label endocytosis of the cells can be analyzed under the fluorescence microscope. But it is also suitable for other nucleic acids like RNA (mRNA, miRNA, and siRNA), and modified nucleic acids (antisense oligonucleotides).
T050-0.5
METAFECTENE® FluoR is designed for transient transfection of mammalian cell lines and primary cells with DNA (plasmids, bacmids). By the fluorescent label endocytosis of the cells can be analyzed under the fluorescence microscope. But it is also suitable for other nucleic acids like RNA (mRNA, miRNA, and siRNA), and modified nucleic acids (antisense oligonucleotides).
T050-1.0
The finding that lipofection is also attacked by the defense measures of the innate immune system led us to develop the K2® Transfection System, consisting of the K2® Transfection Reagent and the K2® Multiplier. The K2® Transfection Reagent is based on powerful cationic lipids (as liposomes), while the Multiplier decreases the cells’ ability to detect nucleic acids. The K2® Transfection System is therefore a further development of the transfection reagent METAFECTENE® PRO.
T060-0.75
The finding that lipofection is also attacked by the defense measures of the innate immune system led us to develop the K2® Transfection System, consisting of the K2® Transfection Reagent and the K2® Multiplier. The K2® Transfection Reagent is based on powerful cationic lipids (as liposomes), while the Multiplier decreases the cells’ ability to detect nucleic acids. The K2® Transfection System is therefore a further development of the transfection reagent METAFECTENE® PRO.
T060-1.0
The finding that lipofection is also attacked by the defense measures of the innate immune system led us to develop the K2® Transfection System, consisting of the K2® Transfection Reagent and the K2® Multiplier. The K2® Transfection Reagent is based on powerful cationic lipids (as liposomes), while the Multiplier decreases the cells’ ability to detect nucleic acids. The K2® Transfection System is therefore a further development of the transfection reagent METAFECTENE® PRO.
T060-2.0
The finding that lipofection is also attacked by the defense measures of the innate immune system led us to develop the K2® Transfection System, consisting of the K2® Transfection Reagent and the K2® Multiplier. The K2® Transfection Reagent is based on powerful cationic lipids (as liposomes), while the Multiplier decreases the cells’ ability to detect nucleic acids. The K2® Transfection System is therefore a further development of the transfection reagent METAFECTENE® PRO.
T060-5.0
The knowledge that virtually all transfection methods are affected of the defenses of the innate immune system led to the development of the K4® Transfection System consisting of the K4® Transfection Reagent and the K4® Multiplier. The K4® Transfection Reagent is based on powerful cationic lipids, whereas the K4® Multiplier decreases the cells´ ability to detect foreign nucleic acids. Especially hard to transfect cells often express endosomal or cytosolic sensors that can detect nucleic acids. In contrast to the K2® Multiplier, the K4® Multiplier as its further development inhibits both groups of sensors.
T080-1.0
The knowledge that virtually all transfection methods are affected of the defenses of the innate immune system led to the development of the K4® Transfection System consisting of the K4® Transfection Reagent and the K4® Multiplier. The K4® Transfection Reagent is based on powerful cationic lipids, whereas the K4® Multiplier decreases the cells´ ability to detect foreign nucleic acids. Especially hard to transfect cells often express endosomal or cytosolic sensors that can detect nucleic acids. In contrast to the K2® Multiplier, the K4® Multiplier as its further development inhibits both groups of sensors.
T080-2.0
The knowledge that virtually all transfection methods are affected of the defenses of the innate immune system led to the development of the K4® Transfection System consisting of the K4® Transfection Reagent and the K4® Multiplier. The K4® Transfection Reagent is based on powerful cationic lipids, whereas the K4® Multiplier decreases the cells´ ability to detect foreign nucleic acids. Especially hard to transfect cells often express endosomal or cytosolic sensors that can detect nucleic acids. In contrast to the K2® Multiplier, the K4® Multiplier as its further development inhibits both groups of sensors.
T080-5.0
